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Most human protein-encoding transcripts contain multiple introns that are removed by splicing. Although splicing catalysis is
frequently cotranscriptional, some introns are excised after polyadenylation. Accumulating evidence suggests that delayed splic-
ing has regulatory potential, but the mechanisms are still not well understood. Here we identify a terminal poly(A) tail as being
important for a subset of intron excision events that follow cleavage and polyadenylation. In these cases, splicing is promoted by
the nuclear poly(A) binding protein, PABPN1, and poly(A) polymerase (PAP). PABPN1 promotes intron excision in the context
of 3=-end polyadenylation but not when bound to internal A-tracts. Importantly, the ability of PABPN1 to promote splicing re-
quires its RNA binding and, to a lesser extent, PAP-stimulatory functions. Interestingly, an N-terminal alanine expansion in
PABPN1 that is thought to cause oculopharyngeal muscular dystrophy cannot completely rescue the effects of PABPN1 deple-
tion, suggesting that this pathwaymay have relevance to disease. Finally, inefficient polyadenylation is associated with impaired
recruitment of splicing factors to affected introns, which are consequently degraded by the exosome. Our studies uncover a new
function for polyadenylation in controlling the expression of a subset of human genes via pre-mRNA splicing.
The majority of human pre-mRNAs contain introns that areremoved by splicing and undergo 3=-end formation by cleav-
age and polyadenylation (CPA). Splicing is a two-step process
requiring 5 small nuclear RNAs (snRNAs) and around 150 pro-
teins (1). A 5= splice site is first bound by U1 snRNA, and after
recognition of the 3= splice site by U2AF65, the intron branch
point is bound by U2 snRNA. Recruitment of U4, U5, and U6
precedes complex rearrangement of the spliceosome, and follow-
ing the release of U1 and U4, splicing catalysis takes place, leading
to exon ligation.
Many splicing factors are recruited to RNA polymerase II (Pol
II) and assemble on introns during transcription (2, 3). Following
these cotranscriptional commitment steps, multiple observations
concur in showing that splicing catalysis is also frequently cotran-
scriptional (4–9). Nevertheless, some splicing catalysis occurs fol-
lowing polyadenylation, i.e., some introns are present in polyade-
nylated RNA, from which they are subsequently excised. This is
more often the case for introns closer to the poly(A) signal, asmay
be expected, since there is less time for splicing prior to CPA (5, 7,
8, 10). Several reports indicate that delayed splicing may have
regulatory potential. First, alternative splicing decisions are often
more posttranscriptional than constitutive splicing events (5, 11).
Second, several reports have shown that splicing of transcripts
induced during the inflammatory response is delayed relative to
CPA (12–14). Third, retained and detained introns modulate the
expression of genes in different cells and in response to stimuli,
respectively (15, 16). Finally, it was recently found thatmany post-
transcriptional splicing events are inhibited during heat shock,
whereas efficient cotranscriptional splicing is less affected (17).
Although these data highlight the existence of delayed intron ex-
cision, the mechanisms are not yet fully understood.
In human cells, splicing proceeds via an exon definitionmech-
anism involving interactions across exons (18). Removal of the
terminal intron requires factors bound to the poly(A) and 3= splice
sites, and mutation of either signal abolishes both splicing and
CPA (19–23). Interactions between trans-acting factors include
the interaction of cleavage and polyadenylation specificity factor
(CPSF) with SF3b and that of U2AF65 with both CF1m and
poly(A) polymerase (PAP) (24–28). The involvement of PAP in
splicing in vitro suggests a possible function for polyadenylation in
splicing in vivo.
Transcripts destined for splicing following polyadenylation
possess a poly(A) tail, which is not present during cotranscrip-
tional splicing. Polyadenylation occurs following cleavage at the
poly(A) site and is performed by PAP. By itself, PAP is relatively
inefficient, but its activity is enhanced by CPSF and the nuclear
poly(A) binding protein, PABPN1 (29–35). PABPN1 plays an ad-
ditional role in the regulation of poly(A) site selection (36).While
efficient polyadenylation has an integral mRNAmaturation func-
tion, inefficient polyadenylation is associated with degradation by
the exosome (37–40). Although the exosome plays a general role
in the turnover of aberrant RNA, it can function in competition
with mRNA maturation in Saccharomyces cerevisiae (41, 42). The
relevance of polyadenylation to human health is clear from the
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number of diseases that are associated withmutations in PABPN1
and with alterations in polyadenylation (43–46). For instance, an
N-terminal alanine expansion in PABPN1 leads to oculopharyn-
geal muscular dystrophy (OPMD) (46, 47).
In the present study, we reveal a stimulatory function for a
poly(A) tail in the splicing of transcripts synthesized from chro-
mosomally integrated-globin and a subset of endogenous genes.
This requires PAP, PABPN1, and a terminal poly(A) tail, whereas
internal adenine tracts bound by PABPN1 are unable to stimulate
splicing. Complementation experiments further delineate that
both the RNA binding and PAP-stimulatory functions of
PABPN1 are important for intron excision in this context. Inter-
estingly, anN-terminal alanine expansion of PABPN1 is not com-
pletely functional in this process. Finally, exosome depletion sta-
bilizes pre-mRNAs whose splicing is sensitive to polyadenylation.
Our findings illuminate an important new function of polyade-
nylation in the splicing and degradation of a subset of human
pre-mRNAs.
MATERIALS AND METHODS
Primers and siRNAs. Details of the primers and small interfering RNAs
(siRNAs) are provided in the supplemental material.
Stable cell line construction. We previously described the pcDNA5
FRT/TO plasmid containing the WT -globin (WT) gene (19). The 
ribozyme (RZ) was made by annealing sense and antisense oligonucleo-
tides containing its sequence before their insertion into a vector prepared
by PCR amplification of theWTgenewith-globin cloning vector F and
R primers. The poly(A) tail was added by subsequent PCR with primers
incorporating theA-stretch. The histone stem-loopwas incorporated into
the  RZ by using tagged PCR primers containing its sequence. The
MEN triplex-encoding sequence was synthesized by Integrated DNA
Technologies and inserted directly upstreamof the RZ. Internal A-tracts
were inserted by PCR amplification of the WT gene with internal A 20,
40, or 60 forward and reverse primers, as appropriate. For rescue of
PABPN1 depletion (see Fig. 6), a DNA that coded for the expression of
carboxy-terminally Flag-tagged PABPN1 that was RNA interference
(RNAi) resistant was synthesized by Genewiz (see Fig. S1 in the supple-
mental material). This was cloned in place of the -globin gene in the
WTplasmid usingGibsonAssembly (NewEnglandBioLabs). Pointmu-
tations were made by site-directed mutagenesis. See the supplemental
material for all primer sequences.
Cell culture. All cells were grown in Dulbecco’s modified Eagle’s me-
dium (DMEM) supplemented with 10% fetal calf serum. For transient
transfection, 3 g of reporter plasmid was transfected using JetPrime
(Polyplus), and assays were performed 24 h later. For RNAi, siRNAs were
transfected into 30-mm dishes by using Lipofectamine RNAiMax (Life
Technologies) following the manufacturer’s guidelines. For PABPN1
RNAi, cells were harvested at 72 h posttransfection. For all other deple-
tions (and for PABPN1 [see Fig. 8]), two successive siRNA transfections
were performed. Stable cell lines were generated by transfecting Flp-IN
HEK cells with 3g of -globin plasmid and 7g pOG44, using JetPrime
(Polyplus) transfection reagent, in a 50% confluent 100-mm dish. At 48 h
posttransfection, cells were transferred to a tissue culture flask and grown
in the presence of hygromycin (100 g/ml) and blasticidin (10 g/ml)
until resistant cells emerged. Transcription was induced by growth in
medium supplemented with 1 g/ml tetracycline.
Antibodies. PAP (NBP1-30060; Novus), PAP (A301-009A;
Bethyl), PABPN1 (ab75855; Abcam),-actin (AM1021B; Abgent),-glo-
bin (sc-21757; Santa Cruz), histone H3 (ab1791; Abcam), and U2AF65
(U4758; Sigma) antibodies were used.
RNA isolation. Total RNA was isolated using TRIzol (Life Technolo-
gies). Generally, 1 ml of TRIzol was used directly on a 6-well dish of cells
following the manufacturer’s guidelines.
UV cross-linking and RNA immunoprecipitation. Cells were rinsed
twice with ice-cold phosphate-buffered saline (PBS), immediately UV
irradiated at 400 mJ/cm2 (  245 nm) by using a Stratalinker 1800
apparatus (Stratagene), and then scraped into ice-cold PBS. The cell pellet
was resuspended in 400 l of lysis buffer (50 mM Tris-HCl, pH 7.5, 100
mM NaCl, 1% NP-40, 0.1% SDS, 0.5% sodium deoxycholate) supple-
mented with protease inhibitors, incubated on ice for 10 min, and soni-
cated for 10 min (30 s on/30 s off; high setting; Bioruptor instrument).
Cellular debris was then pelleted at 13,000 	 g for 10 min at 4°C. The
resulting supernatant was treated with DNase for 1 h at 37°C in the pres-
ence of an RNase inhibitor and protease inhibitors and then further son-
icated for 10 min. The lysates were then added to protein A/G Dynabeads
(Invitrogen) preincubated for 2 h with antibodies (2 g per immunopre-
cipitation [IP]). No-antibody controls were performed in parallel. Fol-
lowing overnight rotation at 4°C, the beads were washed twice in wash
buffer (20mMTris-HCl, pH 7.5, 10mMMgCl2, 0.2%Tween 20), twice in
high-salt buffer (50 mM Tris-HCl, pH 7.5, 1 M NaCl, 1 mM EDTA, 1%
NP-40, 0.1% SDS, 0.5% sodium deoxycholate), twice in wash buffer, and
once in proteinase K buffer (50 mM Tris-HCl, pH 7.5, 10 mM MgCl2,
0.5% NP-40, 50 mM NaCl). RNA was then eluted from the beads for 1 h
at 50°C by using 50 l elution buffer (1	 proteinase K buffer supple-
mented with 1% SDS and 20 g proteinase K). RNA was phenol-chloro-
form extracted and ethanol precipitated. The RNA was then treated with
Turbo DNase for 1 h, phenol-chloroform extracted, and ethanol precip-
itated. Half of the RNA was reverse transcribed, and the other half was
used for a parallel, no-reverse-transcriptase control.
Northern blotting. In general, 3 g RNA was used. RNase H treat-
ment involved prior incubation of the RNA with 100 pmol oligonucleo-
tide and RNaseH for 1 h at 37°C. After phenol-chloroform extraction and
ethanol precipitation, RNAswere separated in a 5%denaturing polyacryl-
amide gel and electroblotted onto a Hybond-N nylon membrane (Amer-
sham Biosciences). The membrane was probed with a 5=-terminally la-
beled oligonucleotide complementary to-globin exon 3 (-globin ex3 R
probe).
RT-qPCR. For reverse transcription-quantitative PCR (RT-qPCR),
RNAwas treated with TurboDNase (Ambion) before RT using Inprom II
(Promega). cDNA was generally diluted to 30 to 50 l, of which 1 l was
used for real-time PCR in conjunction with Brilliant III SYBR mix (Agi-
lent Technologies) in a Qiagen Rotorgene machine. Parallel reactions
were always performed in the absence of reverse transcriptase to establish
that the signals obtained were not due to DNA contamination. Compar-
ative quantitation was used to derive the results. Unless otherwise stated,
RT was primed with random hexamers (Qiagen) to detect all transcripts.
Quantitation. Real-time PCR experiments were quantitated as fol-
lows. For each biological replicate, RNA values were first normalized to a
reference transcript. The control sample in the set was then given an
arbitrary value of 1, and the test samples were quantitated relative to this
value. This procedure was repeated for at least three biological replicates
per experiment. In the presented graphs, the average fold differences were
plotted together with the standard deviations. Student’s t test was used to
establish the significance of any differences.
RESULTS
Synthetic cleavage and polyadenylation support splicing and
gene expression in humans. It is well known that splicing and
CPA are linked through terminal exon definition, and we previ-
ously analyzed the function of individual snRNAs in maintaining
this coupling (19). In the present study, we set out to understand
how CPA couples 3=-end formation to splicing. We developed a
system where CPA could occur in the absence of a poly(A) signal,
using the -globin gene as a reporter. We replaced its poly(A)
signal with either a self-cleaving ribozyme (RZ) from hepatitis 
(to create ) or the same RZ preceded by 46 adenines (A46)
(Fig. 1A). This RZ has been shown to cleave rapidly and efficiently
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in a variety of contexts in cells (48–50). The native gene (WT)
and these two variants were stably integrated, in single copy, into
HEK293 cells. Transcription was driven by a tetracycline (tet)-
inducible cytomegalovirus (CMV) promoter.
To test the ability of the modified -globin genes to support
splicing, we performed reverse transcription-quantitative PCR
(RT-qPCR) analysis of each cell line after overnight induction
with tet. Following cDNA synthesis with randomhexamers, qPCR
was used to detect unspliced intron 1 (Ex1-In1) and intron 2 (In2-
Ex3), as well as spliced exons 1 and 2 (Ex1-Ex2) and spliced exons
2 and 3 (Ex2-Ex3) (Fig. 1B). We also measured the efficiency of
splicing by calculating the ratio of spliced to unspliced RNA for
both introns. The levels of these species in  and A46 samples
were quantitated relative to those obtained from WT cells (Fig.
1C). In the case of , some unspliced pre-mRNA was present,
albeit at a reduced level for In2-Ex3, but very little spliced mRNA
was detected. This shows that 3=-end formation by an RZ instead
of a poly(A) site does not support mRNA synthesis, which is con-
cordant with prior studies (48). In contrast, the levels of unspliced
and spliced transcripts obtained from A46 cells were very sim-
ilar to those fromWTcells, as was the splicing efficiency. Indeed,
Western blotting confirmed that equivalent levels of -globin
protein were produced in theWTandA46 cell lines (Fig. 1D).
This is consistent with a previous report demonstrating that syn-
thetic 3=-end formation allows gene expression in budding yeast
(51). Importantly, however, we additionally showed that this syn-
thetic CPA supports pre-mRNA splicing in human cells.
Stabilizing nonpolyadenylated 3= ends does not promote
splicing. The ability of the templated A-tract to support splicing
might be explained by RNA stability effects, since we reproducibly
observed smaller amounts of unspliced intron 2 (In2-Ex3) for 
than forWTorA46. To test this hypothesis, we generated two
more cell lines, in which the 3= RZ was preceded by a histone
stem-loop (His) or an RNA triplex derived from the noncoding
MEN transcript (MEN) (Fig. 2A). These structures have
been shown to stabilize 3= ends (49, 52). Importantly, the MEN
triplex is predicted to sequester the 3= end of the RNA within the
secondary structure, leaving it unavailable for polyadenylation.
We isolated RNAs from WT, A46, , His, and MEN
cells and analyzed unspliced (In2-Ex3) and spliced (Ex2-E3)
-globin intron 2, together with the splicing efficiency (Fig. 2B).
As before, splicing levels of WT and A46 were essentially
equivalent, and splicing of  RNA was poor, with reduced levels
of In2-Ex3 transcripts again seen. The presence of the histone
stem-loop upstream of the RZ restored In2-Ex3 levels to normal,
but there was still very little spliced RNA present, indicating that
simply stabilizing the 3= end was insufficient to support intron
removal. This was also evident for MEN cells, in which pre-
mRNA was stabilized 4-fold compared to that in WT cells but
splicing efficiency was similar to that in  cells.
We wished to ascertain the polyadenylation status of A46
transcripts, so we performed Northern blotting on RNAs from
WT and A46 cells (Fig. 2C). As a negative control, we also
analyzed MEN transcripts, which are predicted to be non-
FIG 1 A 3=-templated poly(A) tail supports -globin splicing. (A) Diagrams of WT, , and A46 genes with 3= transcript features. Exons are indicated
as boxes, and the tetracycline-inducible CMV promoter is shown as an arrow. The following distinguishing features at the 3= ends of the encoded
transcripts are also shown: the poly(A) signal (AAUAAA) for WT, the  RZ for , and the A46 template and  RZ for A46. (B) Diagram illustrating
primers and amplicons used for RT-qPCR analysis of -globin splicing. Exons are numbered. We analyzed splicing efficiency by dividing the signal for
spliced RNA by that obtained for the unspliced precursor. (C) Quantitation of RT-qPCR results for analysis of -globin splicing in cells expressing WT,
, or A46. The level of each RNA species was normalized to the glyceraldehyde-3-phosphate dehydrogenase (GAPDH) mRNA level and is shown
relative to that recovered from WT cells, which was given a value of 1. (D) Western blot analysis of -globin protein isolated from WT or A46 cells
either uninduced or induced with tet for 5 and 14 h, as indicated. -Actin is shown as a loading control. All error bars represent standard deviations for
at least three biological replicates. *, P 
 0.05; **, P 
 0.01.
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polyadenylated due to the 3=triple-helical structure. To obtain a
high-resolution view of the 3= polyadenylation status, RNAwithin
-globin exon 3 was cleaved by using an oligonucleotide and
RNase H before gel electrophoresis. WT transcripts were ob-
served as a smear, consistent with the presence of a poly(A) tail—
something that we confirmed by oligo(dT) andRNaseHdigestion
(see Fig. S2A in the supplemental material). Interestingly, A46
transcripts also appeared as a smear rather than a distinct band,
indicating a further polyadenylation of theRZ-cleaved end thatwe
confirmed by sequencing (see Fig. S2B). Finally, MEN tran-
scripts are not subject to polyadenylation, as they were present as
a single, sharp band corresponding to the RZ cleavage site. We
concluded that A46 transcripts are further polyadenylated,
whereas MEN transcripts are not, and that a 3= poly(A) tail
supports -globin pre-mRNA splicing but other stable nonpoly-
adenylated termini do not.
PABPN1 depletion inhibits splicing that follows poly(A) site
cleavage. We next sought to identify factors recruited to the
poly(A) tail that might promote splicing. In humans, nuclear
poly(A) tails are bound by PABPN1, which plays an important
role in defining the tail length by stimulating and controlling PAP
(29–31). To test for a function of PABPN1 in splicing, it was de-
pleted from WT and A46 HEK cells by RNAi (Fig. 3A). RT-
qPCR was then used to detect unspliced and spliced intron 1 and
intron 2 and to determine their respective splicing efficiencies
(Fig. 3B). In both cell lines, PABPN1 depletion caused significant
reductions in spliced RNA and splicing efficiency for intron 2.
Consistent with this, RNA immunoprecipitation experiments
showed that PABPN1 binds to unspliced -globin transcripts (see
Fig. S3 in the supplemental material).
To test the dependence of the PABPN1 effect on the presence of
introns, we constructed another cell line (cDNA) containing in-
tronless -globin with its native poly(A) site. The WT and
cDNA cell lines were treated with control or PABPN1 siRNA,
and total RNA was isolated. RT-qPCR was then performed to
analyze the level of Ex2-Ex3 transcripts (Fig. 3C). Fewer tran-
scripts were produced from the cDNA gene; however, while
PABPN1 depletion reduced the Ex2-Ex3 product in WT cells, it
had no effect in cDNA cells. This strongly suggests that WT
mRNA is depleted by PABPN1 knockdown, at least in part, due to
a pre-mRNA splicing defect. Indeed, a recent report found no
effect of PABPN1 on the stability of -globin mRNA following
splicing, although its levels were reduced (53).
Any effect of PABPN1 on splicing is expected to be dependent
on a poly(A) tail and therefore requires prior CPA. To test this, we
designed primers to detect spliced and unspliced RNAs that were
not cleaved at the poly(A) site (Fig. 3D). Next, we performed
RT-qPCR by using these primers on samples extracted from con-
trol and PABPN1-depleted WT cells. As described above, we
quantitated the levels of spliced and unspliced RNAs, as well as
their ratio (as a measure of splicing efficiency). Importantly,
PABPN1 did not affect splicing in this assay, consistent with a
requirement for a poly(A) tail.
Internal A-tracts recruit PABPN1 but do not promote splic-
ing.Wenext wanted to test whether the effect of PABPN1was due
specifically to its recruitment to the poly(A) tail or related to its
function in activating PAP. To do this, we engineered a panel of
-globin plasmids in which 20, 40, or 60 adenines were inserted
within -globin exon 3 (Fig. 4A). This was performed in the
context of the MEN construct because the MEN element
prevents further polyadenylation following RZ cleavage (Fig.
2C). Importantly, further Northern analysis confirmed that
A60MEN 3= ends are not subject to polyadenylation (see
Fig. S4 in the supplemental material). To test whether PABPN1
could bind the internal A-tracts, we performed RNA immunopre-
cipitation with cells transfected with the WT, MEN,
A20MEN, A40MEN, and A60MEN plasmids, using
the PABPN1 antibody (Fig. 4B). RT-qPCR was used to detect
unspliced (In2-Ex3) transcripts, which were bound efficiently by
PABPN1 in WT samples. For comparison, PABPN1 bound very
poorly to MEN transcripts, consistent with their lack of a
poly(A) tail. Importantly, PABPN1was effectively recruited to the
internal A-tracts, with a binding efficiency correlating positively
FIG 2 Stable, nonpolyadenylated 3= ends do not support -globin splicing.
(A) Diagrams of His and MEN genes integrated into HEK cells. The
symbols are the same as in Fig. 1A. The histone stem-loop and MEN RNA
triplex are represented diagrammatically. (B) Quantitation of RT-qPCR re-
sults for analysis of-globin exon 2 and 3 splicing in cells expressingWT,,
A46, His, or MEN. The level of each RNA species was normalized to
the GAPDH mRNA level and is shown relative to that recovered from WT
cells, which was given a value of 1. (C) Northern blot analysis of cells trans-
fected with WT, A46, and MEN plasmids. RNAs were cleaved by an
oligonucleotide targeting-globin exon 3 before being resolved in the gel. The
gel was probed with a 5=-labeled probe targeting exon 3. All error bars repre-
sent standard deviations for at least three biological replicates. *, P
 0.05; **,
P
 0.01.
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with the number of A’s. This system therefore uncouples 3=-ter-
minal polyadenylation fromPABPN1 recruitment, since PABPN1
can bind to internal A-tracts yet the 3= ends of these MEN-
based transcripts cannot be polyadenylated.
To check the ability of internally bound PABPN1 to promote
splicing, we tested the efficiency of -globin intron 2 removal
in cells transfected with WT, MEN, A20MEN,
A40MEN, and A60MEN by using RT-qPCR (Fig. 4C).
Similar to the case in the stable cell lines, MEN transcripts
were poorly spliced compared to the WT transcripts; however,
the -globin splicing efficiency was also low for A20MEN,
A40MEN, and A60MEN. This shows that although
PABPN1 can bind these internal A-tracts, this binding is insuffi-
cient to stimulate splicing following RZ cleavage, consistent with
the results of a previous report (54). Thus, simply recruiting
PABPN1 to anA-tract does not stimulate intron removal, unless it
occurs in the context of a terminal poly(A) tail.
Poly(A) polymerase is needed for efficient splicing. We next
set out to explain how PABPN1 aids splicing only in the context of
a 3= poly(A) tail. The best-characterized function of PABPN1
bound to poly(A) tails is to stimulate PAP (29–31). An involve-
ment of PABPN1 in stimulating PAP predicts that depletion of
polyadenylation activity will also affect splicing.We depleted both
PAP and PAP from cells, which is required to reduce polyade-
nylation activity in vivo (53). After confirming successful RNAi
(Fig. 4D), WT and A46 cells were treated with control or
PAP/ siRNA and subjected to RT-qPCR analysis to detect in-
tron 2 (In2-Ex3), spliced exons 2 and 3 (Ex2-Ex3), and splicing
efficiency (Fig. 4E). Like PABPN1 depletion, PAP knockdown re-
duced WT splicing efficiency, supporting a role for polyadenyl-
ation in splicing. Importantly, PAP depletion inhibited A46
splicing, suggesting that polyadenylation also contributes to the
effect of the terminal poly(A) tail on intron removal following RZ
cleavage.
PAP and PABPN1 are important for a subset of endogenous
splicing events. A recent study addressed the global impact of
PABPN1 depletion onmRNA levels and found that, inmost cases,
it had little effect (50). However, 227 mRNAs were shown to be
reduced 2-fold in this analysis. In light of our findings, we hy-
pothesized that inefficient splicing may explain some of these ob-
servations. To test this, five of the downregulated transcripts were
selected for further study (PSMB3, PRDX2, LXN, ATP5G1, and
WFDC1). TheMyc transcriptwas used as a negative control, as the
published transcriptome sequencing (RNA-seq) results revealed
FIG3 PABPN1 is needed for efficient polyadenylation and splicing of-globin transcripts. (A)Western blot analysis of PABPN1 inWTandA46 cells treated
with control (siCont) or PABPN1-specific (siPABPN1) siRNA. -Actin is shown as a loading control. (B) Quantitation of RT-qPCR results for analysis of
-globin splicing in WT and A46 cells treated with control or PABPN1-specific siRNA. The level of each RNA species is shown as the fold change compared
to the level in control siRNA-treated cells after normalization to GAPDHmRNA. (C) RT-qPCR results for Ex2-Ex3 RNA in stableWTandcDNA cells treated
with control or PABPN1 siRNA. Values are quantitated relative to those obtained for control siRNA-transfected WT cells after normalization to GAPDH
mRNA. (D) RT-qPCR analysis of cotranscriptional exon 2 and 3 splicing in WT cells treated with control or PABPN1-specific siRNA. The level of each RNA
species is shown as the fold change compared to the level in control siRNA-treated cells after normalization to GAPDHmRNA. The diagram shows the primers
used for PCR analysis. All error bars represent standard deviations for at least three biological replicates. *, P
 0.05.
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no impact of PABPN1 on its expression. As a positive control for
PABPN1 effects, we analyzed the SHG60 noncoding RNA, which
is degraded in a PABPN1-dependent manner (50). We initially
tested terminal intron removal, as we expected it to be most sus-
ceptible to amechanism of splicing occurring after CPA (Fig. 5A).
PABPN1 depletion caused an increase in the levels of unspliced
PSMB3, PRDX2, LXN, ATP5G1, and WFDC1 transcripts, with a
corresponding reduction in splicing efficiency, but no effect was
observed in the case of Myc. This pathway is distinct from that
controlling SHG60 RNA, as PABPN1 depletion stabilized only
spliced transcripts in that case. RNA immunoprecipitation analy-
sis confirmed that PABPN1 bound efficiently to unspliced
PSMB3, PRDX2, LXN, ATP5G1, andWFDC1 transcripts (see Fig.
S5 in the supplemental material).
Our -globin data showed that terminal intron splicing was
more affected byPABPN1depletion thanproximal intron splicing
and that the effect was specific to transcripts that had undergone
CPA. Consistent with these findings, PABPN1 depletion had a
much smaller effect on the splicing of more promoter-proximal
PSMB3, PRDX2, LXN, ATP5G1, and WFDC1 introns (Fig. 5B).
Moreover, the splicing of PSMB3, PRDX2, and ATP5G1 tran-
scripts that had not undergone CPA was also unaffected, as mea-
sured using a reverse primer beyond the poly(A) site (Fig. 5C).
Note that LXN1 and WFDC1 were not analyzed in Fig. 5C, be-
FIG 4 An internal A-tract does not promote splicing in the absence of a 3=-terminal poly(A) tail. (A) Schematics of WT and AnMEN plasmids, with the
positions of the internal A-tracts within exon 3 indicated. Other symbols are the same as in Fig. 1A. (B) RNA immunoprecipitation to assay the level of unspliced
-globin RNAs bound by PABPN1 in HeLa cells transiently transfected with the WT, MEN, A20MEN, A40MEN, or A60MEN construct.
Values are expressed as % input following normalization to PSMB3 pre-mRNA levels. (C) RT-qPCR analysis of -globin exon 2 and 3 splicing in HeLa cells
transiently transfectedwith theWT,MEN,A20MEN,A40MEN, orA60MEN construct. The level of eachRNA species was quantitated relative
to that recovered from cells transfected with the WT construct, which was given a value of 1. (D) Western blot analysis of PAP and PAP proteins in cells
treated with control or PAP- and PAP-specific siRNAs. Histone H3 is shown as a loading control. (E) RT-qPCR analysis of exon 2 and 3 splicing in WT and
A46 cells treated with control or PAP- and PAP-specific siRNAs. The level of each RNA species is shown as the fold change compared to the level in control
siRNA-treated cells after normalization to GAPDHmRNA. All error bars represent standard deviations for at least three biological replicates. *, P
 0.05; **, P

 0.01. US, unspliced; Spl, spliced.
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cause we were unable to amplify across the final exon to down-
stream of the poly(A) site by real-time PCR.
Results for -globin stable cell lines and reporters demon-
strated that polyadenylation, rather than PABPN1 itself, mediated
the poly(A) tail effect on splicing. Indeed, poly(A) tails were
shorter on PRDX2 pre-mRNAs following PABPN1 depletion (see
Fig. S6 in the supplemental material). To test this on endogenous
transcripts, terminal intron splicing was analyzed for PSMB3,
PRDX2, LXN, ATP5G1, and WFDC1 in control or PAP/-de-
pleted cells (Fig. 5D). In line with our -globin data, PAP/
FIG 5 Splicing of a subset of endogenous transcripts requires PABPN1 and PAP. (A) RT-qPCR analysis of Myc, PSMB3, PRDX2, LXN, ATP5G1, and WFDC1
terminal intron splicing, as well as SHG60 noncoding RNA splicing, in PABPN1-depleted cells. The graph shows fold changes in PABPN1-depleted cells relative
to control cells after normalization toGAPDHmRNA. (B) RT-qPCR analysis of PSMB3 intron 2, PRDX2 intron 1, LXN intron 1, ATP5G1 intron 2, andWFDC1
intron 1 splicing in PABPN1-depleted cells. The graph shows fold changes in PABPN1-depleted cells relative to control cells after normalization to GAPDH
mRNA. (C) RT-qPCR analysis of PSMB3, PRDX2, and ATP5G1 cotranscriptional terminal intron splicing in cells treated with control or PABPN1-specific
siRNA. The graph shows fold changes in PABPN1-depleted cells relative to control cells after normalization to GAPDHmRNA. (D) RT-qPCR analysis of Myc,
PSMB3, PRDX2, LXN, ATP5G1, and WFDC1 terminal intron splicing in PAP- and PAP-codepleted cells. The graph shows fold changes in PAP- and
PAP-codepleted cells relative to control cells after normalization to GAPDHmRNA. (E) RT-qPCR analysis of PSMB3, PRDX2, and ATP5G1 cotranscriptional
terminal intron splicing in PAP- and PAP-codepleted cells. The graph shows fold changes in PAP- and PAP-codepleted cells relative to control cells after
normalization to GAPDHmRNA. All error bars represent standard deviations for at least three biological replicates. *, P
 0.05; **, P
 0.01.
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depletion reduced the efficiency of splicing in each case. As ex-
pected, this effect required poly(A) site cleavage, as PAP/
knockdown did not affect cotranscriptional splicingmeasured us-
ing a reverse primer beyond the PSMB3, PRDX2, and ATP5G1
poly(A) signals (Fig. 5E).
The RNA binding and PAP-stimulating functions of
PABPN1 are important for splicing. To more robustly test and
define the function of polyadenylation in splicing, we developed a
system whereby PABPN1 expression could be restored in cells in
which the native protein had been depleted byRNAi.We also used
this complementation system to test whether key mutants of
PABPN1 could support splicing. These were the F215A mutant,
which cannot bind RNA (55); the L136A mutant, which cannot
stimulate PAP (29); and the Ala17 mutant, which contains an
expanded tract of alanine at its N terminus that causes OPMD
(46). Stable HEK cell lines were constructed to express RNAi-
resistant WT, F215A, L136A, and Ala17 versions of PABPN1 un-
der the control of a tet-inducible CMV promoter. The efficacy of
the systemwas confirmed byWestern blotting, which showed that
endogenous PABPN1 was depleted by RNAi and that tet induc-
tion complemented its loss with the appropriate mutant version
(Fig. 6A). Note that tet was added only after PABPN1 was already
depleted.
Next, RT-qPCR was used to analyze PSMB3 (Fig. 6B) and
PRDX2 (Fig. 6C) splicing in all four cell lines, treated with either
control siRNA, PABPN1 siRNA, or PABPN1 siRNA and then tet.
In WT cell lines, PABPN1 RNAi increased the level of unspliced
RNA, as we had observed before (P 0.055 for PSMB3 and P
0.059 for PRDX2), and reduced the level of spliced transcripts.
The effect was not as large as that in Fig. 5, whichmight have been
due to leakage of the tet promoter resulting in some RNAi-resis-
tant PABPN1 expression even in the absence of tet. Crucially, tet
addition to PABPN1-depleted cells restored unspliced and spliced
RNAs to normal levels.
In L136A cell lines, there was again an increase in pre-mRNA
levels and a reduction in spliced RNAs caused by PABPN1 deple-
tion in the absence of tet. When L136A PABPN1 was induced,
there was some recovery of spliced PRDX2 and PSMB3 RNAs but
not of their unspliced precursors. Thus, splicing efficiency mea-
sured by the ratio of spliced to unspliced RNAwas not restored to
the level seenwhenWTPABPN1was induced.Most strikingly, the
F215A RNA binding mutation rendered PABPN1 completely un-
able to restore pre-mRNA and mRNA levels or splicing efficiency
to cells depleted of native PABPN1. These experiments provide an
insight into the nature of this splicing mechanism.While efficient
polyadenylation plays some role, as the L136A mutant does not
completely support splicing, the F215A mutation has no restor-
ative effect on splicing as determined by the measures used here.
We concluded that PABPN1 binding to 3=-end poly(A) tails un-
derlies its function in splicing and that its ability to stimulate poly-
adenylation may be required for full efficiency.
Complementation of PABPN1 loss with the expression of
Ala17 PABPN1 restored the amounts of unspliced pre-mRNAs to
control levels, suggesting that the Ala17 mutant functions nor-
mally in the metabolism of these species. However, the Ala17mu-
tation could not rescue the level of spliced PSMB3 or PRDX2
transcripts, which remained low following induction in PABPN1-
depleted cells. Althoughmodest, these effects were statistically sig-
nificant and potentially reveal a new effect of the OPMD-associ-
ated alanine expansion on mRNA biogenesis.
PABPN1 depletion reduces the cross-linking of splicing fac-
tors to terminal introns. PAP has been shown to bind U2AF65 in
vitro, thereby promoting splicing (28). This suggests that polyad-
enylation may enhance the recruitment of U2AF65 to affected
introns in cells. To test this, we UV-cross-linked control and
PABPN1-depleted cells and immunoprecipitated transcripts by
using an antibody to U2AF65, which plays a well-established role
in terminal exon definition (19, 27, 28). UV cross-linking fixes
only direct RNA-protein contacts, enabling us to determine
whether the binding of U2AF65 to RNA is affected by PABPN1
depletion. We used RT-qPCR to analyze upstream and terminal
introns from the PRDX2 and PSMB3 genes (Fig. 7A). In both
cases, a modest but significant reduction in U2AF65 binding to
terminal intronswas seen following PABPN1depletion.However,
there was little difference in the recovery of upstream introns,
which do not depend onPABPN1 for their splicing (Fig. 5). Cross-
linking was necessary to stringently observe these differences,
which were not apparent in its absence (see Fig. S7 in the supple-
mental material).
We next performed the same experiment by using an antibody
to phosphorylated SF3b155 that specifically detects only activated
spliceosomes (Fig. 7B) (56). Similar to U2AF65, less phosphory-
lated SF3b155 was cross-linked to PSMB3 and PRDX2 terminal
introns in PABPN1-depleted cells. As for U2AF65, no difference
in cross-linking was observed for upstream introns. These data
strongly suggest that PABPN1 and polyadenylation promote the
binding of splicing factors to introns. This effect is specific to
introns affected by polyadenylation, as those further upstream
recruit splicing factors equivalently in control and PABPN1-de-
pleted cells.
The core exosome and its Rrp6 cofactor target unspliced pre-
mRNAs following PABPN1 depletion. The data described so far
show that disruption of the polyadenylation mechanism impairs
splicing of a selected set of pre-mRNAs and that this is associated
with reduced splicing factor recruitment to affected introns. The
RNA exosome complex has been shown to degrade unspliced
RNAs and inefficiently polyadenylated transcripts in yeast (37,
42). To test whether this pathway monitors polyadenylation-sen-
sitive splicing events, we depleted cells of the nuclear exosome
cofactor, Rrp6. We also analyzed cells depleted of PABPN1 or
codepleted of PABPN1 and Rrp6. RT-qPCR was then used to de-
tect unspliced and spliced PSMB3 and PRDX2 transcripts as well
as the SHG60 noncoding RNA (Fig. 8A). As expected, PABPN1
depletion resulted in an increase in the level of unspliced RNA,
with a corresponding reduction in the recovery of spliced tran-
scripts. Rrp6 depletion alone did not significantly affect the level of
unspliced or spliced PRDX2 and PSMB3 RNAs, suggesting that it
does not degrade them in the presence of fully efficient polyade-
nylation. However, there was a striking stabilization of unspliced
transcripts from both genes when Rrp6 and PABPN1 were code-
pleted. This was not accompanied by any substantial change in the
levels of spliced transcripts relative to those with PABPN1 single
depletion. In the case of SHG60, neither Rrp6 nor PABPN1 deple-
tion affected unspliced RNA levels, but their codepletion resulted
in stabilization of this species. These data demonstrate that when
PABPN1 is depleted, unspliced precursor transcripts are degraded
in an Rrp6-dependent manner.
We next sought to ablate core exosome activity and did so by
depleting its Rrp40 component. Again, cells were also treated with
PABPN1 siRNAs or codepleted of PABPN1 and Rrp40, and
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PSMB3 and PRDX2 terminal intron splicing was assayed by RT-
qPCR (Fig. 8B). As before, the level of unspliced RNA was in-
creased following depletion of PABPN1, with the spliced tran-
script level and splicing efficiency being reduced. Unlike for Rrp6,
Rrp40 depletion alone stabilized unspliced PSMB3 and PRDX2
transcripts, indicating that they are degraded by the core exosome
even in the presence of functional polyadenylation. Like the case
forRrp6 depletion, thiswas not accompanied by a reduction in the
FIG 6 Splicing requires the RNAbinding and PAP-stimulating functions of PABPN1. (A)Western blot analysis of PABPN1 in PABPN1WT, L136A, F215A, and
Ala17 cell lines treated with control or PABPN1 siRNA or with PABPN1 siRNA and then tet. The histoneH3 protein is shown as a loading control. (B) RT-qPCR
analysis of PSMB3 terminal intron splicing in PABPN1WT, L136A, F215A, and Ala17 cell lines treated with control or PABPN1-specific siRNA or with PABPN1
siRNA and then tet. The levels of spliced and unspliced RNAs are shown, as well as their ratios. In each case, quantitation was performed relative to amounts
recovered from cells transfected with control siRNA, which were given a value of 1 after normalization to GAPDHmRNA. (C) The same as panel B, but PRDX2
splicing was analyzed. All error bars represent standard deviations for at least three biological replicates. *, P
 0.05; **, P
 0.01.
Muniz et al.
2226 mcb.asm.org July 2015 Volume 35 Number 13Molecular and Cellular Biology
level of spliced RNA. Codepletion of PABPN1 and Rrp40 had a
synergistic effect on the stability of PSMB3 pre-mRNA but not
PRDX2 pre-mRNA. Rrp40 had an effect similar to that of Rrp6 on
SHG60 transcripts, with the exception that its sole depletion sta-
bilized spliced SHG60RNAs. These data demonstrate that PRDX2
and PSMB3 pre-mRNAs are subject to core exosome-dependent
turnover, but their spliced transcripts are not. The lack of an exo-
some effect on spliced mRNA levels further argues that their re-
duction following PABPN1 depletion is due to less efficient splic-
ing rather than to degradation.
DISCUSSION
In this study, we showed that a terminal poly(A) tail promotes the
removal of a subset of human introns and that this involves PAP
and PABPN1. The removal of polyadenylation-sensitive introns is
monitored by the exosome: its core complex targets these pre-
mRNAs constitutively, whereas its nuclear cofactor, Rrp6, is only
active following PABPN1 knockdown. Interestingly, Ala17
PABPN1 cannot fully restore spliced RNA levels to PABPN1-de-
pleted cells, suggesting that mRNA biogenesis may be affected in
OPMD.
Our data demonstrate that the polyadenylation effect is largely
specific to terminal intron splicing. This aligns with genome-wide
data demonstrating that poly(A) proximal introns are more fre-
quently spliced following polyadenylation (6–8). It is also consis-
tent with established models for exon definition whereby splicing
is functionally coupled toCPA (20–22). CPSF is a key factor in this
process, and its binding to AAUAAA is controlled by PABPN1
(24, 25, 30). Although our data provide evidence that polyadenyl-
ation helps to recruit splicing factors, it is possible that PABPN1
and PAP depletion also prevents CPSF fromparticipating in splic-
ing. PABPN1 has also been shown to suppress poly(A) signals
(36), whose activation might disrupt splicing. We find this possi-
bility unlikely, because PAP depletion also inhibits splicing, and
under such conditions, PABPN1 would presumably remain able
to inhibit poly(A) signals.
The number of splicing events sensitive to polyadenylation is
limited based on the fact that very fewmRNAs are downregulated
following PABPN1 depletion (50). For polyadenylation to affect
splicing, poly(A) site cleavage must have occurred before intron
excision. An obvious factor that could influence this order of
events is having a strong poly(A) signal and relatively weak splice
FIG 7 Polyadenylation promotes the binding of splicing factors to affected
introns. (A) UV cross-linking followed by immunoprecipitation of RNA from
control or PABPN1-depleted cells with a U2AF65 antibody. RT-qPCR was
used to analyze upstream or terminal introns from the PRDX2 and PSMB3
genes. The graph shows percentages of input after normalization to Myc In2-
Ex3 transcripts. (B) UV cross-linking followed by immunoprecipitation of
RNA from control or PABPN1-depleted cells with an antibody to phosphor-
ylated SF3b155. RT-qPCR was used to analyze upstream or terminal introns
from the PRDX2 and PSMB3 genes. The graph shows percentages of input
after normalization to Myc In2-Ex3 transcripts. All error bars represent stan-
dard deviations for at least three biological replicates. *, P
 0.05.
FIG 8 The nuclear and core exosomes degrade PSMB3 and PRDX2 pre-
mRNAs. (A) RT-qPCR analysis of control cells and cells depleted of Rrp6,
PABPN1, or both Rrp6 and PABPN1. Spliced and unspliced SHG60, PRDX2,
and PSMB3 transcripts were analyzed. Values are shown as fold changes rela-
tive to the levels in control samples following normalization to GAPDH
mRNA. Note that PABPN1 effects are larger than those in previous figures
because two rounds of siRNA transfection were performed. (B) RT-qPCR
analysis of control cells and cells depleted of Rrp40, PABPN1, or both Rrp40
and PABPN1. Spliced and unspliced SHG60, PRDX2, and PSMB3 transcripts
were analyzed. Values are shown as fold changes relative to the levels in control
samples following normalization to GAPDH mRNA. Note that PABPN1 ef-
fects are larger than those in previous figures because two rounds of siRNA
transfection were performed. All error bars represent standard deviations for
at least three biological replicates. *, P
 0.05; **, P
 0.01.
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sites in the terminal intron. A visual analysis of sequences around
the 3= splice site of the 5 genes thatwe studied did not highlight any
obvious features that would make them weak. Indeed, the data in
Fig. 7 suggest that affected introns recruit U2AF65 and phosphor-
ylated SF3b155 at least as efficiently as unaffected upstream in-
trons. Very strong poly(A) signals may not provide the explana-
tion, because one of our studied transcripts, ATP5G1, has a
noncanonical AUUAAA hexamer. It is likely that a combination
of factors influences the rate of splicing catalysis versus poly(A)
site cleavage and that, when the latter occurs first, polyadenylation
increases the efficiency of subsequent intron removal.
In each scenario where we observe reduced splicing, PAP func-
tion or recruitment is reduced. For instance, RNAi of PAP/
inhibits splicing, and point mutations in PABPN1 that impair its
RNA binding or PAP-stimulating functions do not support splic-
ing. Finally, PABPN1 cannot promote splicing when tethered to
an internal A-tract in the absence of a terminal polyadenylation
reaction. A likely model to explain these data would involve the
direct recruitment of splicing factors by PAP, which is tethered to
the poly(A) tail most stably in the presence of PABPN1. This is
supported by reduced binding of splicing factors to affected in-
trons when PABPN1 is depleted and by the confirmed role of PAP
in promoting U2AF65 binding to introns in vitro (Fig. 7) (28).
Interestingly, biochemical characterization of L136, which is nec-
essary for fully efficient splicing in our experiments, showed that it
is required to stimulate polyadenylation but not for PABPN1 to
bindRNAand tether PAP (29, 30). Therefore, even in the presence
of PAP, efficient polyadenylation may improve the efficiency of
splicing, possibly by favoring intron excision over pre-mRNA
turnover, thus improving mRNA output.
It is well known that polyadenylation efficiency discriminates
stable, functional transcripts from rapidly degraded aberrant
RNAs (37, 38). This predicts effects of PABPN1 and PAP deple-
tion on RNA turnover. Indeed, knockdown of either the core exo-
some (via Rrp40) or its nuclear cofactor, Rrp6, stabilizes both
PSMB3 and PRDX2 pre-mRNAs. This effect is evident for Rrp6
only when PABPN1 is codepleted, suggesting that this factor is
directed to transcripts only when polyadenylation is impaired.
However, Rrp40 depletion stabilized pre-mRNAs even when
PABPN1was still present. This suggests that polyadenylation-sen-
sitive splicing events are in competition with degradation by the
core exosome. Interestingly, spliced transcripts showed no sub-
stantial exosome effect, indicating that quality control occurs ex-
clusively prior to intron removal. An analogous mechanism was
recently uncovered in Schizosaccharomyces pombe, in which the
poly(A) binding protein, Pab2, regulates the expression of some
spliced transcripts via turnover of their pre-mRNA (57). These
data are consistent with a model whereby weak splicing events are
monitored by the exosome and, furthermore, where polyadenyl-
ation plays a key role in determining whether transcripts are pro-
cessed or degraded.
There are many ways in which polyadenylation can be regu-
lated to provide scope to change the balance between processing
and turnover that we describe. PAP is subjected to a wide range of
posttranslational modifications in eukaryotes to regulate its activ-
ity. For instance, phosphorylation inhibits PAP during the M
phase of the cell cycle, and its nuclear localization stability and
association with CPA factors are disrupted by acetylation and su-
moylation (58–60). Finally, PARylation of PAPoccurs during heat
shock, which inhibits polyadenylation (61). Consistent with our
data, heat shock also causes widespread inhibition of posttran-
scriptional splicing, whereas many efficient cotranscriptional
splicing events are unaffected (17). Further analyses are required
to establish whether regulation of polyadenylation interleaves
with splicing and exosome function to modulate gene expression.
Finally, an N-terminal alanine expansion causes OPMD, but
the molecular mechanism for the disease is not well characterized
(46). Nevertheless, several reports indicate a propensity for the
mutant protein to form nuclear aggregates (62). One possible
consequence of these aggregates is the depletion of functional
PABPN1 from the cell in a dominant negative fashion. In support
of this hypothesis, overexpression of the Ala17 mutant recapitu-
lates the effect of PABPN1 knockdown in terms of the effects on
poly(A) site selection. Moreover, data in the present study reveal
that the Ala17 mutant only partially restores spliced PRDX2 and
PSMB3 mRNAs to PABPN1-depleted cells, whereas splicing is
fully rescued by the wild-type protein. The possible disease rele-
vance of PABPN1 function in alternative CPA and poly(A) tail-
dependent splicing is an interesting topic for further study.
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